83 FR 53491 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 205 (October 23, 2018)

Page Range		53491-53492
FR Document		2018-23069

Federal Register, Volume 83 Issue 205 (Tuesday, October 23, 2018)

[Federal Register Volume 83, Number 205 (Tuesday, October 23, 2018)]
[Notices]
[Pages 53491-53492]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-23069]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-2: NCI Clinical and Translational R21 and Omnibus R03.
    Date: November 7, 2018.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W112, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W112, Bethesda, MD 20892-9750, 240-276-5864, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Collaborative Human Tissue Network (CHTN) (UM1).
    Date: November 14, 2018.
    Time: 10:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W122, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W122, Bethesda, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SBIR Phase IIB Bridge Awards.
    Date: November 15, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee A--Cancer Centers.
    Date: November 29, 2018.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review 
Officer, Office of Referral, Review, and Program Coordination, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-9750, 240-
276-6442, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Center Support Grant (P30).
    Date: November 29, 2018.
    Time: 4:30 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review 
Officer, Office of Referral, Review, and Program Coordination, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center

[[Page 53492]]

Drive, Room 7W530, Bethesda, MD 20892-9750, 240-276-6442, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 17, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-23069 Filed 10-22-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 205 / Tuesday, October 23, 2018 / Notices 53491

Bethesda, MD 20892, 301–827–2864, DEPARTMENT OF HEALTH AND Contact Person: Jennifer C. Schiltz, Ph.D.,
maskerib@mail.nih.gov. HUMAN SERVICES Scientific Review Officer, Special Review
Name of Committee: Center for Scientific Branch, Division of Extramural Activities,
National Institutes of Health National Cancer Institute, NIH, 9609 Medical
Review Special Emphasis Panel; Member
Center Drive, Room 7W112, Bethesda, MD
Conflict: Biobehavioral Applications in 20892–9750, 240–276–5864, jennifer.schiltz@
Ethology and Substance Abuse. National Institute of Diabetes and
nih.gov.
Date: November 15, 2018. Digestive and Kidney Diseases;
Amended Notice of Meeting Name of Committee: National Cancer
Time: 12:00 p.m. to 4:30 p.m. Institute Special Emphasis Panel;
Agenda: To review and evaluate grant Notice is hereby given of a change in Collaborative Human Tissue Network
applications. the meeting of the Diabetes, (CHTN) (UM1).
Place: National Institutes of Health, 6701 Date: November 14, 2018.
Endocrinology and Metabolic Diseases B
Rockledge Drive, Bethesda, MD 20892 Time: 10:30 a.m. to 1:30 p.m.
Subcommittee, October 24, 2018, 05:30 Agenda: To review and evaluate grant
(Virtual Meeting).
p.m. to October 26, 2018, 04:00 p.m., applications.
Contact Person: Andrea B. Kelly, Ph.D.,
Residence Inn Capital View, 2850 South Place: National Cancer Institute, Shady
Scientific Review Officer, Center for
Potomac Avenue, Arlington, VA, 22202 Grove, 9609 Medical Center Drive, Room
Scientific Review, National Institutes of
which was published in the Federal 7W122, Rockville, MD 20850 (Telephone
Health, 6701 Rockledge Drive, Room 3182,
Register on September 12, 2018, 64 FR Conference Call).
MSC 7770, Bethesda, MD 20892, (301) 455– Contact Person: Sanita Bharti, Ph.D.,
1761, kellya2@csr.nih.gov.
46178.
The meeting is being amended to Scientific Review Officer, Research Program
Name of Committee: Center for Scientific Review Branch, Division of Extramural
reflect location change. The new
Review Special Emphasis Panel; AREA Activities, National Cancer Institute, NIH,
meeting location is the Renaissance 9609 Medical Center Drive, Room 7W122,
Application Review.
Washington DC Downtown, 999 9th Bethesda, MD 20892–9750, 240–276–5909,
Date: November 19, 2018.
Street NW, Washington, DC 20001. The sanitab@mail.nih.gov.
Time: 3:00 p.m. to 5:00 p.m.
meeting is closed to the public. Name of Committee: National Cancer
Agenda: To review and evaluate grant
applications. Dated: October 17, 2018. Institute Special Emphasis Panel; SBIR Phase
Place: National Institutes of Health, 6701 David D. Clary, IIB Bridge Awards.
Date: November 15, 2018.
Rockledge Drive, Bethesda, MD 20892 Program Analyst, Office of Federal Advisory Time: 10:00 a.m. to 5:00 p.m.
(Telephone Conference Call). Committee Policy. Agenda: To review and evaluate grant
Contact Person: Katherine M. Malinda, [FR Doc. 2018–23033 Filed 10–22–18; 8:45 am] applications.
Ph.D., Scientific Review Officer, Center for BILLING CODE 4140–01–P Place: National Cancer Institute, Shady
Scientific Review, National Institutes of Grove, 9609 Medical Center Drive, Room
Health, 6701 Rockledge Drive, Room 4140, 7W114, Rockville, MD 20850 (Telephone
MSC 7814, Bethesda, MD 20892, 301–435– DEPARTMENT OF HEALTH AND Conference Call).
0912, Katherine_Malinda@csr.nih.gov. HUMAN SERVICES Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Name of Committee: Center for Scientific
National Institutes of Health Technology and Contract Review Branch,
Review Special Emphasis Panel; AREA
Division of Extramural Activities, National
Application Review. Cancer Institute, NIH, 9609 Medical Center
Date: November 19, 2018. National Cancer Institute; Notice of
Closed Meetings Drive, Room 7W114, Bethesda, MD 20892–
Time: 3:00 p.m. to 5:00 p.m. 9750, 240–276–6371, decluej@mail.nih.gov.
Agenda: To review and evaluate grant Pursuant to section 10(d) of the Name of Committee: National Cancer
applications. Federal Advisory Committee Act, as Institute Initial Review Group Subcommittee
Place: National Institutes of Health, 6701 amended, notice is hereby given of the A—Cancer Centers.
Rockledge Drive, Bethesda, MD 20892 following meetings. Date: November 29, 2018.
(Telephone Conference Call). Time: 8:00 a.m. to 4:00 p.m.
The meetings will be closed to the
Contact Person: Larry Pinkus, Ph.D., Agenda: To review and evaluate grant
public in accordance with the applications.
Scientific Review Officer, Center for
provisions set forth in sections Place: Bethesda Marriott Suites, 6711
Scientific Review, National Institutes of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Democracy Boulevard, Bethesda, MD 20817.
Health, 6701 Rockledge Drive, Room 4132,
as amended. The grant applications and Contact Person: Shamala K. Srinivas,
MSC 7802, Bethesda, MD 20892, (301) 435–
the discussions could disclose Ph.D., Scientific Review Officer, Office of
1214, pinkusl@csr.nih.gov. Referral, Review, and Program Coordination,
confidential trade secrets or commercial
(Catalogue of Federal Domestic Assistance property such as patentable material, Division of Extramural Activities, National
Program Nos. 93.306, Comparative Medicine; and personal information concerning Cancer Institute, NIH, 9609 Medical Center
93.333, Clinical Research; 93.306, 93.333, Drive, Room 7W530, Bethesda, MD 20892–
individuals associated with grant
93.337, 93.393–93.396, 93.837–93.844, 9750, 240–276–6442, ss537t@nih.gov.
applications, the disclosure of which
93.846–93.878, 93.892, 93.893, National Name of Committee: National Cancer
would constitute a clearly unwarranted
Institutes of Health, HHS) Institute Special Emphasis Panel; Cancer
invasion of personal privacy. Center Support Grant (P30).
Dated: October 17, 2018. Name of Committee: National Cancer Date: November 29, 2018.
David D. Clary, Institute Special Emphasis Panel; SEP–2: NCI Time: 4:30 p.m. to 6:00 p.m.
Program Analyst, Office of Federal Advisory Clinical and Translational R21 and Omnibus Agenda: To review and evaluate grant
R03. applications.
khammond on DSK30JT082PROD with NOTICES

Committee Policy.
Date: November 7, 2018. Place: Bethesda Marriott Suites, 6711
[FR Doc. 2018–23035 Filed 10–22–18; 8:45 am]
Time: 11:00 a.m. to 4:00 p.m. Democracy Boulevard, Bethesda, MD 20817
BILLING CODE 4140–01–P Agenda: To review and evaluate grant (Telephone Conference Call).
applications. Contact Person: Shamala K. Srinivas,
Place: National Cancer Institute, Shady Ph.D., Scientific Review Officer, Office of
Grove, 9609 Medical Center Drive, Room Referral, Review, and Program Coordination,
7W112, Rockville, MD 20850 (Telephone Division of Extramural Activities, National
Conference Call). Cancer Institute, NIH, 9609 Medical Center

VerDate Sep<11>2014 20:20 Oct 22, 2018 Jkt 247001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\23OCN1.SGM 23OCN1

53492 Federal Register / Vol. 83, No. 205 / Tuesday, October 23, 2018 / Notices

Drive, Room 7W530, Bethesda, MD 20892– proposed projects. To request more covered by Medicaid, Medicare or
9750, 240–276–6442, ss537t@nih.gov. information on the proposed projects or private insurance offered through the
(Catalogue of Federal Domestic Assistance to obtain a copy of the information exchanges and that demonstrate success
Program Nos. 93.392, Cancer Construction; collection plans, call the SAMHSA in improving outcomes and/or
93.393, Cancer Cause and Prevention Reports Clearance Officer on (240) 276– supporting recovery; (3) to fund
Research; 93.394, Cancer Detection and 1243. universal, selective and targeted
Diagnosis Research; 93.395, Cancer Comments are invited on: (a) Whether prevention activities and services; and
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
the proposed collections of information (4) to collect performance and outcome
93.398, Cancer Research Manpower; 93.399, are necessary for the proper data to determine the ongoing
Cancer Control, National Institutes of Health, performance of the functions of the effectiveness of behavioral health
HHS) agency, including whether the prevention, treatment and recovery
information shall have practical utility; support services and to plan the
Dated: October 17, 2018.
(b) the accuracy of the agency’s estimate implementation of new services on a
Melanie J. Pantoja, of the burden of the proposed collection nationwide basis.
Program Analyst, Office of Federal Advisory of information; (c) ways to enhance the To help states meet the challenges of
Committee Policy. quality, utility, and clarity of the 2020 and beyond, and to foster the
[FR Doc. 2018–23069 Filed 10–22–18; 8:45 am] information to be collected; and (d) implementation and management of an
BILLING CODE 4140–01–P ways to minimize the burden of the integrated physical health, mental
collection of information on health and addiction service system,
respondents, including through the use SAMHSA has established standards and
DEPARTMENT OF HEALTH AND of automated collection techniques or expectations that will lead to an
HUMAN SERVICES other forms of information technology. improved system of care for individuals
with or at risk of mental and substance
National Institutes of Health Proposed Project: Community Mental
use disorders. Therefore, this
Health Services Block Grant and
National Cancer Institute; Amended application package continues to fully
Substance Abuse Prevention and
Notice of Meeting exercise SAMHSA’s existing authority
Treatment Block Grant FY 2020–2021
regarding states’, territories’ and the Red
Plan and Report Guidance and
Notice is hereby given of a change in Lake Band of the Chippewa Tribe’s
Instructions (OMB No. 0930–0168)—
the meeting of the Frederick National (subsequently referred to as ‘‘states’’)
Extension
Laboratory Advisory Committee to the use of block grant funds as they fully
National Cancer Institute, October 29, The Substance Abuse and Mental integrate behavioral health services into
2018, 09:30 a.m. to October 29, 2018, Health Services Administration the broader health care continuum.
04:30 p.m., National Cancer Institute (SAMHSA) is requesting approval from Consistent with previous
Shady Grove, 9609 Medical Center the Office of Management and Budget applications, the FY 2020–2021
Drive, TE406, Rockville, MD, 20850 (OMB) for an extension of the 2018–19 application has sections that are
which was published in the Federal Community Mental Health Services required and other sections where
Register on October 11, 2018, 83 FR Block Grant (MHBG) and Substance additional information is requested. The
51468. Abuse Prevention and Treatment Block FY 2020–2021 application requires
The meeting notice is amended to Grant (SABG) Plan and Report Guidance states to submit a face sheet, a table of
change the start and end time of the and Instructions. contents, a behavioral health assessment
meeting from 9:30 a.m.–4:30 p.m. to Currently, the SABG and the MHBG and plan, reports of expenditures and
9:00 a.m.–4:00 p.m. on October 29, differ on a number of their practices persons served, an executive summary,
2018. The meeting is open to the public. (e.g., data collection at individual or and funding agreements and
aggregate levels) and statutory certifications. In addition, SAMHSA is
Dated: October 17, 2018. authorities (e.g., method of calculating requesting information on key areas that
Melanie J. Pantoja, MOE, stakeholder input requirements are critical to the states success in
Program Analyst, Office of Federal Advisory for planning, set asides for specific addressing health care integration.
Committee Policy. populations or programs, etc.). Therefore, as part of this block grant
[FR Doc. 2018–23070 Filed 10–22–18; 8:45 am] Historically, the Centers within planning process, SAMHSA is asking
BILLING CODE 4140–01–P SAMHSA that administer these block states to identify both their promising or
grants have had different approaches to effective strategies as well as their
application requirements and reporting. technical assistance needs to implement
DEPARTMENT OF HEALTH AND To compound this variation, states have the strategies they identify in their plans
HUMAN SERVICES different structures for accepting, for FYs 2020 and 2021.
planning, and accounting for the block To facilitate an efficient application
Substance Abuse and Mental Health
grants and the prevention set aside process for states, SAMHSA utilized the
Services Administration
within the SABG. As a result, how these questions and requests for clarification
Agency Information Collection dollars are spent and what is known from representatives from SMHAs and
Activities: Proposed Collection; about the services and clients that SSAs to inform the proposed changes to
Comment Request receive these funds varies by block grant the block grants. Based on these
and by state. discussions with states, SAMHSA is
In compliance with Section SAMHSA has conveyed that block
khammond on DSK30JT082PROD with NOTICES

proposing de minimis changes to the
3506(c)(2)(A) of the Paperwork grant funds must be directed toward block grant program, consisting of
Reduction Act of 1995 concerning four purposes: (1) To fund priority updated dates and clarification to
opportunity for public comment on treatment and support services for instructions.
proposed collections of information, the individuals without insurance or who While the statutory deadlines and
Substance Abuse and Mental Health cycle in and out of health insurance block grant award periods remain
Services Administration (SAMHSA) coverage; (2) to fund those priority unchanged, SAMHSA encourages states
will publish periodic summaries of treatment and support services not to turn in their application as early as

VerDate Sep<11>2014 20:20 Oct 22, 2018 Jkt 247001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\23OCN1.SGM 23OCN1

Document Created: 2018-10-23 04:14:14
Document Modified: 2018-10-23 04:14:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 7, 2018.
FR Citation		83 FR 53491

83 FR 53491 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 205 (October 23, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health